» Articles » PMID: 21252989

Adipokines in Inflammation and Metabolic Disease

Overview
Journal Nat Rev Immunol
Date 2011 Jan 22
PMID 21252989
Citations 1862
Authors
Affiliations
Soon will be listed here.
Abstract

The worldwide epidemic of obesity has brought considerable attention to research aimed at understanding the biology of adipocytes (fat cells) and the events occurring in adipose tissue (fat) and in the bodies of obese individuals. Accumulating evidence indicates that obesity causes chronic low-grade inflammation and that this contributes to systemic metabolic dysfunction that is associated with obesity-linked disorders. Adipose tissue functions as a key endocrine organ by releasing multiple bioactive substances, known as adipose-derived secreted factors or adipokines, that have pro-inflammatory or anti-inflammatory activities. Dysregulated production or secretion of these adipokines owing to adipose tissue dysfunction can contribute to the pathogenesis of obesity-linked complications. In this Review, we focus on the role of adipokines in inflammatory responses and discuss their potential as regulators of metabolic function.

Citing Articles

Neuropsychiatric Abnormalities in Metabolic Disturbances: Interplay of Adipokines and Neurotransmission.

Cheon S, Song J Mol Neurobiol. 2025; .

PMID: 40042730 DOI: 10.1007/s12035-025-04797-6.


Body weight in systemic lupus erythematosus is associated with disease activity and the adaptive immune system, independent of type I IFN.

Teruya H, Shoda H, Itamiya T, Tsuchida Y, Okamura T, Fujio K Front Immunol. 2025; 16:1503559.

PMID: 40040694 PMC: 11876045. DOI: 10.3389/fimmu.2025.1503559.


Abdominal obesity and frailty progression in population across different Cardiovascular-Kidney-Metabolic syndrome stages: a nationwide longitudinal study.

Zhang C, Hao C, Liang W, Hu K, Guo T, Chen Y Diabetol Metab Syndr. 2025; 17(1):75.

PMID: 40033331 PMC: 11877786. DOI: 10.1186/s13098-025-01649-0.


Blockade of the vaspin-AP-1 axis inhibits arthritis development.

Jeon J, Cho C, Kim S, Kim H, Lee H, Kim S Exp Mol Med. 2025; .

PMID: 40025171 DOI: 10.1038/s12276-025-01418-z.


Physical Activity and Depression in Breast Cancer Patients: Mechanisms and Therapeutic Potential.

Li A, Zheng X, Liu D, Huang R, Ge H, Cheng L Curr Oncol. 2025; 32(2).

PMID: 39996878 PMC: 11854877. DOI: 10.3390/curroncol32020077.


References
1.
Lo J, Bernstein L, Canavan B, Torriani M, Jackson M, Ahima R . Effects of TNF-alpha neutralization on adipocytokines and skeletal muscle adiposity in the metabolic syndrome. Am J Physiol Endocrinol Metab. 2007; 293(1):E102-9. PMC: 3196534. DOI: 10.1152/ajpendo.00089.2007. View

2.
Chatterjee T, Stoll L, Denning G, Harrelson A, Blomkalns A, Idelman G . Proinflammatory phenotype of perivascular adipocytes: influence of high-fat feeding. Circ Res. 2009; 104(4):541-9. PMC: 2742882. DOI: 10.1161/CIRCRESAHA.108.182998. View

3.
Okamoto Y, Folco E, Minami M, Wara A, Feinberg M, Sukhova G . Adiponectin inhibits the production of CXC receptor 3 chemokine ligands in macrophages and reduces T-lymphocyte recruitment in atherogenesis. Circ Res. 2007; 102(2):218-25. DOI: 10.1161/CIRCRESAHA.107.164988. View

4.
Hosogai N, Fukuhara A, Oshima K, Miyata Y, Tanaka S, Segawa K . Adipose tissue hypoxia in obesity and its impact on adipocytokine dysregulation. Diabetes. 2007; 56(4):901-11. DOI: 10.2337/db06-0911. View

5.
Hotamisligil G . Inflammation and metabolic disorders. Nature. 2006; 444(7121):860-7. DOI: 10.1038/nature05485. View